Market Tracker

10/20 5:16pm ET

Innoviva Inc (NASDAQ:INVA)

13.83
Delayed Data
As of Oct 20
 -0.27 / -1.91%
Today’s Change
8.67
Today|||52-Week Range
14.87
+29.25%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close14.10
Today’s open14.20
Day’s range13.80 - 14.23
Volume422,049
Average volume (3 months)888,190
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+121.51%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio16.9
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.40+1.21%
EBSEmergent BioSolution...+0.28+0.69%
MYOKMyoKardia Inc-0.90-2.38%
LXRXLexicon Pharmaceutic...-0.18-1.59%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.32
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts